Sigyn Therapeutics, Inc.
SIGY
$2.76
-$0.99-26.40%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.84M | -3.25M | -3.34M | -3.99M | -3.70M |
| Total Depreciation and Amortization | 4.20K | 5.60K | 5.70K | 8.00K | 6.50K |
| Total Amortization of Deferred Charges | 716.20K | 852.00K | 856.50K | 1.33M | 1.24M |
| Total Other Non-Cash Items | 1.22M | 353.80K | 341.30K | 344.50K | 86.90K |
| Change in Net Operating Assets | 994.50K | 1.11M | 1.26M | 1.60M | 1.46M |
| Cash from Operations | -900.80K | -931.20K | -872.40K | -710.10K | -910.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 917.70K | 1.01M | 987.90K | 881.90K | 985.40K |
| Total Debt Repaid | -70.00K | -95.00K | -115.00K | -71.60K | -45.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 847.80K | 911.40K | 873.00K | 810.40K | 940.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.10K | -19.90K | 400.00 | 100.10K | 30.00K |